These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 1907520

  • 21. Assessment of the antiarrhythmic profile of the new class I agent diprafenone.
    Gülker H, Thale J, Olbing B, Heuer H, Frenking B, Bender F.
    Arzneimittelforschung; 1985; 35(9):1387-93. PubMed ID: 4084340
    [Abstract] [Full Text] [Related]

  • 22. The role of oral 1C antiarrhythmic drugs in terminating atrial fibrillation.
    Capucci A, Villani GQ, Piepoli MF, Aschieri D.
    Curr Opin Cardiol; 1999 Jan; 14(1):4-8. PubMed ID: 9932201
    [Abstract] [Full Text] [Related]

  • 23. [New aspects of the electrophysiologic effect of antiarrhythmic agents].
    Antoni H, Weirich J.
    Herz; 1990 Apr; 15(2):61-9. PubMed ID: 2188893
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effects of simulated ischaemia on the electrical activity of ventricular myocardium in the presence of antiarrhythmic drugs.
    Németh M, Papp JG.
    Acta Physiol Hung; 1991 Apr; 77(3-4):249-55. PubMed ID: 1755330
    [Abstract] [Full Text] [Related]

  • 26. Calcium channel modulators and susceptibility to ischaemic ventricular fibrillation: modification of cellular calcium overload.
    Timour Q, Larbre JP, Kioueh I, Aupetit JF, Loufoua-Moundanga J, Vialle A, Faucon G.
    Arch Int Pharmacodyn Ther; 1992 Apr; 315():30-46. PubMed ID: 1384452
    [Abstract] [Full Text] [Related]

  • 27. Proarrhythmic actions of flecainide in an isolated tissue model of ischemia and reperfusion.
    Heisler BE, Ferrier GR.
    J Pharmacol Exp Ther; 1996 Oct; 279(1):317-24. PubMed ID: 8859009
    [Abstract] [Full Text] [Related]

  • 28. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
    Klempt HW, Nayebagha A, Fabry E.
    Z Kardiol; 1982 May; 71(5):340-9. PubMed ID: 6180562
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Lack of selectivity for ventricular and ischaemic tissue limits the antiarrhythmic actions of lidocaine, quinidine and flecainide against ischaemia-induced arrhythmias.
    Barrett TD, Hayes ES, Walker MJ.
    Eur J Pharmacol; 1995 Oct 24; 285(3):229-38. PubMed ID: 8575508
    [Abstract] [Full Text] [Related]

  • 38. Use of diprafenone, a new potent propafenone-analogue, in acute experimental myocardial ischaemia and infarction.
    Thale J, Gülker H, Hindricks G, Haverkamp W, Bender F.
    Eur Heart J; 1987 Aug 24; 8 Suppl D():107-15. PubMed ID: 3678251
    [Abstract] [Full Text] [Related]

  • 39. Magnesium--a profibrillatory or antifibrillatory drug depending on plasma concentration, heart rate and myocardial perfusion.
    Aupetit JF, Freysz M, Faucon G, Loufoua-Moundanga J, Coquelin H, Timour Q.
    Acta Anaesthesiol Scand; 1997 Apr 24; 41(4):516-23. PubMed ID: 9150782
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.